Schedule 13D ownership disclosure
THESEUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88369M101
Event date: 2023-12-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 40.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-001179
- Form type
- SC 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Dec 27, 2023
- Reporting period
- Dec 22, 2023
- Description
- Schedule 13D beneficial ownership